1.20. Analysis.
Comparison 1 BUD v Placebo: parallel studies, not on oral steroids: 400 mcg/d or less, Outcome 20 Change in night‐time use of short‐acting beta2 agonists compared to baseline (puffs/night‐time).
Comparison 1 BUD v Placebo: parallel studies, not on oral steroids: 400 mcg/d or less, Outcome 20 Change in night‐time use of short‐acting beta2 agonists compared to baseline (puffs/night‐time).